| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $28,710 | +1,100 | +0.16% | $26.10* | 669,045 | 07 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $161,876 | -1,100 | -0.16% | $147.16 | 667,945 | 07 Jan 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $84,068 | +3,221 | +0.48% | $26.10* | 671,166 | 07 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $469,751 | -3,221 | -0.48% | $145.84 | 667,945 | 07 Jan 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $119,016 | +4,560 | +0.68% | $26.10* | 672,505 | 07 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $660,379 | -4,560 | -0.68% | $144.82 | 667,945 | 07 Jan 2022 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Options Exercise | $213,054 | +8,163 | +1.2% | $26.10* | 676,108 | 07 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $1,174,737 | -8,163 | -1.2% | $143.91 | 667,945 | 07 Jan 2022 | Direct | F1, F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1,100 | -0.81% | $0.000000 | 135,245 | 07 Jan 2022 | Common Stock | 1,100 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3,221 | -2.4% | $0.000000 | 132,024 | 07 Jan 2022 | Common Stock | 3,221 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4,560 | -3.5% | $0.000000 | 127,464 | 07 Jan 2022 | Common Stock | 4,560 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -8,163 | -6.4% | $0.000000 | 119,301 | 07 Jan 2022 | Common Stock | 8,163 | $26.10 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $146.71 to $147.68. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $145.42 to $146.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $144.41 to $145.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $143.41 to $144.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |